Combination of selective COX-2 inhibitor and lung surfactant for respiratory syndrome

Details for Australian Patent Application No. 2002336933 (hide)

Owner ALTANA PHARMA AG

Inventors Hafner, Dietrich

Agent Griffith Hack

Pub. Number AU-A-2002336933

PCT Number PCT/EP02/08176

PCT Pub. Number WO2003/011316

Priority 01118540.2 01.08.01 EP

Filing date 23 July 2002

Wipo publication date 17 February 2003

International Classifications

A61K 038/17 Medicinal preparations containing peptides - from animals

A61P 011/00 Drugs for disorders of the respiratory system

Event Publications

20 February 2003 Complete Application Filed

  Priority application(s): 01118540.2 01.08.01 EP

29 May 2003 Application Open to Public Inspection

  Published as AU-A-2002336933

3 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002336934-SLEEVE CARRIER FOR SHIFTING A TOOTHED WHEEL IN A GEAR BOX

2002336932-IMPROVED RECT OR RECET CLONING AND SUBCLONING METHOD